Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy

A disease outbreak in December 2019, caused by a novel coronavirus SARS-CoV-2, was named COVID-19. SARS-CoV-2 infects cells from the upper and lower respiratory tract system and is transmitted by inhalation or contact with infected droplets. Common clinical symptoms include fatigue, fever, and cough...

Full description

Bibliographic Details
Main Authors: Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michal Sekrecki, Hanna Nowicka, Natalia Lopacinska, Arta Olya, Katarzyna Kluzek, Joanna Wesoly, Hans A. R. Bluyssen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
COVID – 19
interferon response
immune hyperactivation
multiple organ damage
STAT signaling
Statinhib
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.888897/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.888897/full

Similar Items